peopleInnovationCareers RarePipelineCollaborationFinanceAdvance treatment
Hansa Biopharma
HNSA (, %) SEK
Hansa Biopharma
Man presenterar för en publik i ett möte

Presentationer

Delad Presentation

Page: /

Investor Road Show Presentation Q3 2023

Visa presentation
Aktie på mobilen

Senaste presentationer

08 dec 2023

Carlsquare Life Science Investor Day

23 nov 2023

Redeye Life Science Day 2023

31 okt 2023

Matt Shaulis Q3 Intervju med Erik Penser Bank

Kalender

Kommande evenemang

14
dec

Redeye Investor Forum, Göteborg

08
jan

JPM Week, San Francisco

02
feb

Full-year Report for January-December 2023

Se alla kalenderhändelser

Presentationer

2023PresentationWebcast

08 dec 2023

Carlsquare Life Science Investor Day

23 nov 2023

Redeye Life Science Day 2023

31 okt 2023

Matt Shaulis Q3 Intervju med Erik Penser Bank

26 okt 2023

Investor Road Show Presentation Q3 2023

03 okt 2023

Redeye Theme: Autoimmune and Inflammatory Disease

14 sep 2023

Erik Penser Bolagsdag Malmö

14 sep 2023

Pareto Securities' 14th Annual Healthcare Conference

24 aug 2023

Erik Penser Bolagsdag Stockholm

27 jul 2023

Erik Penser Q2 2023 intervju

27 jul 2023

HCA Q2 2023 intervju

19 jul 2023

Investor Road Show Presentation Q2 2023

18 jul 2023

William Blair Fireside Chat

19 jun 2023

Analyst Lunch Meeting Stockholm

01 jun 2023

Redeye Growth Day 2023

31 maj 2023

ABGSC Life Science Summit Seminar

30 maj 2023

HC Andersen Capital Seminar Autoimmune Diseases

25 maj 2023

Erik Penser Company Day

26 apr 2023

HCA Hansa Biopharma Q1 2023 Intervju

26 apr 2023

Erik Penser Bank - Hansa Biopharma Q1 2023 Intervju

21 apr 2023

Redeye Investor Forum Gothenburg

20 apr 2023

Guggenheim Healthcare Talks

20 apr 2023

Investor Road Show Presentation Q1 2023

15 mar 2023

Redeye Investor Event Commercialization

10 mar 2023

Cowen Healthcare Conference

23 feb 2023

Erik Penser Bolagsdag

03 feb 2023

Hansa Biopharma Q4 intervju med HC Andersen Capital

03 feb 2023

Hansa Biopharma Q4 intervju med Erik Penser Ban

02 feb 2023

Investor Road Show Presentation Q4 2022